Report #2898508

Received Jun 1, 2026

Office visit

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Female
Age: 41 yrs
State: CT
Recovered: Not recovered
Vaccinated: May 20, 2026
Onset: May 20, 2026
Days to onset: 0
Hospital days: —

Vaccines (4)

Type	Name	Manufacturer	Dose	Lot	Route / Site
HPV9	HPV (GARDASIL 9)	MERCK & CO. INC.	1	Z016028	IM / LA
HEP	HEP B (HEPLISAV-B)	DYNAVAX TECHNOLOGIES CORPORATION	1	947988	IM / LA
HPV9	HPV (GARDASIL 9)	MERCK & CO. INC.	1	Z016028	IM / LA
TDAP	TDAP (BOOSTRIX)	GLAXOSMITHKLINE BIOLOGICALS	1	H9DT7	LA

Symptoms (7)

Injection site bruisingInjection site erythemaInjection site painInjection site pruritusInjection site swellingJoint injuryInjected limb mobility decreased

Symptom narrative

Site: Bruising at Injection Site-Severe, Site: Itching at Injection Site-Severe, Site: Pain at Injection Site-Severe, Site: Redness at Injection Site-Severe, Site: Swelling at Injection Site-Severe, Site: Shoulder Joint Injury (prolonged pain, tingling, etc.)-Severe